Bio Pharma Dive
MARCH 14, 2023
“A generation of founders is now scarred,” one biotech CEO said, as small drugmakers grapple with the longer-lasting effects of SVB’s stunning collapse
Pharmaceutical Technology
MARCH 14, 2023
The National Health Surveillance Agency (ANVISA) in Brazil has granted approval for Takeda ’s dengue virus vaccine candidate, Qdenga (Dengue Tetravalent Vaccine [Live, Attenuated]) (TAK-003). The vaccine has received approval for preventing dengue disease in people aged four years to 60 years.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Bio Pharma Dive
MARCH 14, 2023
Responding to policy changes and pressure over high drug costs, the pharma is reducing the sticker price of four branded diabetes medicines by up to 75
Pharmaceutical Technology
MARCH 14, 2023
The pharmaceutical industry continues to be a hotbed of innovation, with activity driven by the evolution of new treatment paradigms, and the gravity of unmet needs, as well as the growing importance of technologies such as pharmacogenomics, digital therapeutics, and artificial intelligence.
Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist
This webinar will go over the FDA's guidance on pharmacological and toxicological considerations for optimizing doses for prescription drugs.
Bio Pharma Dive
MARCH 14, 2023
The regulator’s review of the planned $43 billion deal could reveal how it plans to apply a new philosophy toward drugmaker mergers
Pharmaceutical Technology
MARCH 14, 2023
Biopharmaceutical firm Cingulate and life sciences commercialisation firm Indegene have entered into a joint commercialisation deal for the former’s attention-deficit/hyperactivity disorder (ADHD) therapy CTx-1301 (dexmethylphenidate).
Clinical Research Informer brings together the best content for clinical researchers from the widest variety of industry thought leaders.
Pharmaceutical Technology
MARCH 14, 2023
Pfizer has entered a definitive merger agreement to buy biotechnology firm Seagen in a deal valued at $43bn. Under the deal, the company would pay $229 per Seagen share in cash. Both companies’ Board of Directors have unanimously approved the transaction.
Bio Pharma Dive
MARCH 14, 2023
The company’s name comes from its goal of developing drugs that only “switch” on in target cells, potentially enabling more precise therapies
Pharmaceutical Technology
MARCH 14, 2023
The pharmaceutical industry continues to be a hotbed of innovation, with activity driven by the evolution of new treatment paradigms, and the gravity of unmet needs, as well as the growing importance of technologies such as pharmacogenomics, digital therapeutics, and artificial intelligence.
Pharma Times
MARCH 14, 2023
The clinical trial also involves paclitaxel in the treatment of metastatic breast cancer
Advertiser: FourKites
Download this a benchmark study from FourKites and The Journal of Commerce exploring how international shippers’ usage of global supply chain visibility technology has evolved since the onset of global disruptions caused by COVID-19.
Pharmaceutical Technology
MARCH 14, 2023
The pharmaceutical industry continues to be a hotbed of innovation, with activity driven by the evolution of new treatment paradigms, and the gravity of unmet needs, as well as the growing importance of technologies such as pharmacogenomics, digital therapeutics, and artificial intelligence.
Pharma Times
MARCH 14, 2023
Candidate AP30663 is an inhibitor for the conversion of atrial fibrillation to a normal sinus rhythm
BioSpace
MARCH 14, 2023
Embattled CytoDyn Sets New Course Toward NASH, Tough Tumors 3/15/2023
Fierce Pharma
MARCH 14, 2023
After $3.4B deal and EU withdrawal, Novartis looks to sell Xiidra: Bloomberg aliu Tue, 03/14/2023 - 09:39
Speaker: Steve Goldstein, Sales Leader
Currently in sales or involved in a business that depends on strong sales results? Join Steve Goldstein, Sales Success Coach, Motivational Speaker and Medical Device Sales Leader from Gold Selling LLC. You will absorb critical strategies to become a trusted partner in greater sales success.
BioPharma Reporter
MARCH 14, 2023
The new Clinical Biotechnology Centre (CBC) in Bristol will expand the UKâs ability to make clinical grade products for the research and development of new cell and gene therapies. Bio Developments
Fierce Pharma
MARCH 14, 2023
Novo Nordisk follows Eli Lilly's lead, slashing insulin prices in the US kdunleavy Tue, 03/14/2023 - 10:56
XTalks
MARCH 14, 2023
Pfizer recently announced that their novel migraine nasal spray Zavzpret (zavegepant), received US Food and Drug Administration (FDA) approval for the acute treatment of migraines (with or without aura) in adults.
Fierce Pharma
MARCH 14, 2023
In industrywide price-fixing case, Sun Pharma opts to settle for $75M fkansteiner Tue, 03/14/2023 - 10:12
Advertiser: Aggregage
The federal government is developing a rule requiring employers with more than 100 employees ensure their workers are vaccinated or produce a negative COVID test weekly before entering the workplace. So, what can your organization do to prepare? Get Paycor’s COVID Vaccination Policy Template to help communicate important details to your employees.
BioSpace
MARCH 14, 2023
How Executive Pay Packages are Negotiated 3/15/2023
Drug Channels
MARCH 14, 2023
I am pleased to announce our new 2023 Economic Report on U.S. Pharmacies and Pharmacy Benefit Managers , available for purchase and immediate download.
BioSpace
MARCH 14, 2023
Strategy Behind Lowered Insulin Prices: Novo Nordisk and Eli Lilly 3/15/2023
Fierce Pharma
MARCH 14, 2023
After Medicare rejection, Eisai and Biogen's Leqembi gets thumbs-up from Veterans Administration kdunleavy Tue, 03/14/2023 - 07:11
BioSpace
MARCH 14, 2023
Novartis and Pfizer-Backed Mediar Nets $85M for Fibrosis Paradigm Shift 3/15/2023
Fierce Pharma
MARCH 14, 2023
Chasing Pfizer, GSK's 5-in-1 meningococcal vaccine delivers phase 3 trial win zbecker Tue, 03/14/2023 - 09:52
Pharma Marketing Network
MARCH 14, 2023
Pharma Business Blog
MARCH 14, 2023
Siamo lieti di invitarvi al nostro evento “Pharma & Life Science Get Together Ticino” nato dalla collaborazione tra PwC e Farma Industria Ticino (FIT) per presentarvi alcune novità in ambito regolatorio e fiscale di rilevanza per le società del settore farmaceutico.
Roots Analysis
MARCH 14, 2023
Clinical trials are a fundamental requirement for evaluating the safety and efficacy of novel therapeutic interventions. Initiating a clinical trial is a complex and time-consuming process, involving suitable planning and execution.
BioSpace
MARCH 14, 2023
Veru Moves Forward with Late-Stage COVID Study Despite FDA Roadblock 3/15/2023
FDA Law Blog
MARCH 14, 2023
By Larry K. Houck — Like EF Hutton television commercials of the 1970s and ‘80s, when Attorney General Merrick Garland talks, people listen. With Hutton it was about investing, for the Attorney General it is cannabis. AG Garland most recently talked cannabis during a Senate Judiciary Committee hearing last week when Senator Cory Booker (D-NJ) asked about the Department of Justice’s (“DOJ’s”) review of cannabis and when we might expect policy changes.
BioSpace
MARCH 14, 2023
Bellicum Weighs Options After Serious Safety Concerns Halt Only Trials 3/15/2023
BioSpace
MARCH 14, 2023
Concentra's Buy Offer May Jeopardize Jounce's Merger with Redx 3/15/2023
Expert insights. Personalized for you.
309 
Let's personalize your content